Health Secretary Robert F. Kennedy Jr. appeared before Congress this week to defend his department's handling of infectious disease outbreaks, asserting that the United States is containing measles more effectively than the rest of the world despite mounting concerns over declining vaccination rates.

In his first substantive congressional testimony in months, Kennedy faced pointed questions from lawmakers about the administration's public health messaging and its impact on immunization coverage. The hearing comes at a delicate moment: while measles cases have spiked dramatically in several countries, the US has so far avoided the scale of outbreaks seen elsewhere, though public health experts warn that could change.

"The data speaks for itself," Kennedy told the House Energy and Commerce Committee. "We are managing these outbreaks with greater success than our international counterparts, and we're doing it while respecting parental choice and medical freedom."

A Global Resurgence

The context for Kennedy's testimony is a worldwide measles crisis that has caught many health systems off guard. According to the World Health Organization, global measles cases increased by more than 20 percent in 2025 compared to the previous year, with major outbreaks reported in parts of Europe, Southeast Asia, and sub-Saharan Africa.

The highly contagious virus, which was declared eliminated in the United States in 2000, has made sporadic comebacks in recent years, typically linked to international travel and pockets of under-vaccinated communities. The two-dose MMR vaccine is approximately 97 percent effective at preventing measles, but protection requires high coverage rates—generally above 95 percent—to maintain what epidemiologists call "herd immunity."

That threshold has become harder to maintain. Childhood vaccination rates in the US dipped during the COVID-19 pandemic and have not fully recovered. The CDC reported last year that roughly 93 percent of kindergarteners had received their MMR vaccines, down from 95 percent pre-pandemic. In some communities, particularly in certain counties across the Mountain West and Pacific Northwest, rates have fallen considerably lower.

Questions of Causation

Kennedy's critics argue that his long history of vaccine skepticism—he has questioned vaccine safety for years, though he insists he is not "anti-vaccine"—has contributed to growing hesitancy among parents. Since his confirmation as Health Secretary in early 2025, several state health departments have reported increased requests for vaccine exemptions and a rise in parents delaying or refusing recommended immunizations.

"Secretary Kennedy may point to current case numbers, but the real measure of his tenure will be what happens in the coming months and years," said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, in an interview with The New England Journal of Medicine. "Measles doesn't forgive complacency. Once vaccination rates drop below critical thresholds, outbreaks become inevitable."

During the hearing, Democratic members of the committee pressed Kennedy on whether his public statements had undermined confidence in vaccines. Representative Anna Eshoo of California cited a recent Kaiser Family Foundation poll showing that parental trust in childhood vaccines had declined by eight percentage points since 2024.

Kennedy pushed back, arguing that his approach emphasized transparency and informed consent rather than mandates. "Parents deserve honest information about benefits and risks," he said. "What we've seen is that when you trust people with information, rather than talking down to them, you get better outcomes."

The Numbers in Dispute

The factual basis of Kennedy's central claim—that the US is outperforming other countries in measles control—depends heavily on how one measures success. In absolute terms, the United States has reported fewer than 200 confirmed measles cases so far in 2026, according to preliminary CDC data. That compares favorably to countries like Romania and the Philippines, which have each reported thousands of cases.

However, public health experts note that the US benefits from infrastructure, resources, and baseline vaccination coverage that many countries lack. Comparing raw case numbers without accounting for population size, healthcare capacity, and starting vaccination rates can be misleading.

"It's a bit like congratulating yourself for having fewer house fires than a country without a fire department," said Dr. Jennifer Nuzzo, an epidemiologist at Brown University School of Public Health. "The question isn't just where we are today, but whether we're maintaining the systems that got us here."

Some Republican lawmakers defended Kennedy's record, pointing to the administration's efforts to streamline vaccine injury compensation and increase funding for vaccine safety research. Representative Cathy McMorris Rodgers of Washington praised what she called a "more balanced approach" to public health policy.

International Comparisons

The measles situation varies dramatically by region. In Europe, several countries have struggled with outbreaks linked to declining MMR coverage, particularly in communities with high levels of vaccine hesitancy. The United Kingdom recently reported its largest measles outbreak in over a decade, concentrated in areas where vaccination rates had fallen below 85 percent.

In contrast, several Asian countries with robust national immunization programs have maintained near-zero measles transmission despite higher population density. Japan and South Korea, for instance, have sustained vaccination rates above 97 percent and reported fewer than a dozen cases each last year.

The comparison Kennedy drew appears to focus primarily on wealthy nations with similar healthcare infrastructure, rather than a global average that includes countries facing conflict, poverty, or collapsed health systems. Public health researchers have noted that such selective comparisons can obscure important context.

The Road Ahead

What remains unclear is whether the current US measles numbers represent sustainable success or a temporary reprieve. Measles outbreaks often follow unpredictable patterns, with cases clustering in specific communities before spreading more widely. The virus can circulate silently among vaccinated populations—who typically experience mild or no symptoms—while posing serious risks to infants too young for vaccination and immunocompromised individuals.

The CDC has identified several ongoing measles clusters in states including Ohio, Texas, and Arizona, though none have yet escalated into the kind of large-scale outbreak that occurred in New York in 2019, which resulted in over 1,200 cases. Health departments in those states have implemented aggressive contact tracing and offered free MMR vaccines to potentially exposed individuals.

Kennedy told lawmakers that his department was "monitoring the situation closely" and had no plans to alter current vaccine recommendations. He emphasized investments in disease surveillance and outbreak response capacity, though he did not address questions about whether his public messaging might be contributing to lower vaccination uptake.

As the hearing concluded, Kennedy faced a final question from Representative Frank Pallone of New Jersey about what he would say to parents who had lost children to vaccine-preventable diseases. Kennedy paused before responding that "every child's health matters," and that his goal was to ensure that families had access to both vaccines and information.

For public health officials watching the testimony, the concern is less about today's measles count than about tomorrow's. In a disease as contagious as measles, the gap between safety and crisis can close with startling speed.